Evaluation of New Diagnostic Indicator of Subclinical Hypercortisolism
NCT04833192 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 202
Last updated 2022-04-15
Summary
The purpose of this study is to evaluate the serum dehydroepiandrosterone sulfate in subclinical hypercortisolism
Conditions
- Adrenal Incidentaloma
- Subclinical Hypercortisolism
Interventions
- DIAGNOSTIC_TEST
-
experimental group
DHEAS.24h-UFC,ACTH and cortisol are measured in the experimental group
Sponsors & Collaborators
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-04-01
- Primary Completion
- 2023-04-01
- Completion
- 2023-12-30
Countries
- China
Study Locations
More Related Trials
-
Comparison of Intramuscular and Intravenous ACTH Stimulation Test in Normal Volunteers
NCT03752190 ·Status: WITHDRAWN ·Phase: PHASE4
-
Clinical Outcome of Autonomous Cortisol Secretion in Adrenal Incidentalomas
NCT04917757 ·Status: ACTIVE_NOT_RECRUITING
-
Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT)
NCT01546922 ·Status: COMPLETED ·Phase: PHASE4
-
Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism(ADOPA)
NCT04461535 ·Status: COMPLETED ·Phase: NA
-
Hair Cortisol and Cushing's Disease
NCT04201444 ·Status: COMPLETED ·Phase: NA
-
The Effects of Two Brands of Hydrocortisone Injected Intramuscularly Into Deltoid and Thigh Muscles
NCT05350020 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
NCT00004343 ·Status: UNKNOWN
-
A Study of Markers of Glucocorticoid Effects in Patients With Addisons Disease (DOSCORT)
NCT03210545 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
NCT00796783 ·Status: TERMINATED
-
Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency
NCT01450930 ·Status: COMPLETED ·Phase: PHASE2
-
Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
NCT03760835 ·Status: RECRUITING ·Phase: PHASE4
-
Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy
NCT03708523 ·Status: UNKNOWN
-
The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome Diagnosis
NCT02791698 ·Status: UNKNOWN
-
Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests
NCT02818660 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
NCT00434148 ·Status: COMPLETED ·Phase: PHASE3
-
Cortisol Response to Adrenocorticotrophin (ACTH) in Acute Stress
NCT00493389 ·Status: UNKNOWN ·Phase: NA
-
Biomarker(s) for Glucocorticoids
NCT02152553 ·Status: COMPLETED ·Phase: NA
-
Standardized 1µg Adrenocorticotropic Hormone Stimulation Test, and Salivary Cortisol Concentration During the Test
NCT02413944 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults
NCT01088399 ·Status: COMPLETED
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism
NCT06381323 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
NCT05063994 ·Status: COMPLETED ·Phase: PHASE3
-
The Factors Associated With the Recurrence in Patients With Cushing Disease
NCT02233335 ·Status: COMPLETED
-
The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory Diseases
NCT03575247 ·Status: COMPLETED
-
Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome
NCT06801249 ·Status: RECRUITING ·Phase: PHASE4